Pre-results note
Growth continues; Combisafe in focus - Q3 preview
Mathias Carlson
2026-10-05
16:35 CEST
We expect Q3 sales of SEK335m (+16% Y/Y), adj. EBITA of SEK27m (+13% Y/Y) and an adj. EBITA margin of 8.1% (8.3% in Q3 2025). In our view, continued organic growth should support earnings, although Combisafe’s initial losses will likely temper margin progress. Investor focus should be on UK demand, integration execution and cash conversion, in our view. We lower our 2026e EPS by 11% but maintain our fair value range of SEK27–37.
Growth continues; margin progression remains uneven. We forecast organic growth of 9% Y/Y and a gross margin of 36%. Scaffolding Systems and Digital Solutions should underpin earnings, while UK Work Zone Safety remains the swing factor. Evidence that the improved UK activity noted in Q2 is converting into orders and sales would strengthen confidence in the recovery, in our view.
Combisafe adds strategic scope, but near-term earnings dilution. The acquisition adds cSEK80m in annual sales and access to nine additional European markets. HAKI expects cSEK26m of restructuring and integration costs mainly in H2 2026; the Q3/Q4 split is undisclosed. Seller funding partially covers these costs, according to the company. These one-offs are excluded from our adj. EBITA and adj. EPS estimates. However, we expect operating losses during the H2 restructuring period, driving our 11% EPS cut. Workforce reductions and depot consolidation should support profitability from 2027e, but delivery against management’s ambition for margins above the group average remains key, in our opinion.
Internal CEO appointment supports execution. CFO Tomas Hilmarsson is set to become CEO on 1 November 2026. We view this positively: he has performed strongly as CFO and knows the businesses, acquisition agenda and financial priorities. In our view, this should preserve momentum and could accelerate the growth strategy, with less transition risk at a time when integration and capital discipline are particularly important.